1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Demographic and clinical characteristics of MS
MSP Value
Baseline6 Months12 Months
Sample size181818NA
Female:male13:513:513:5NA
Age (yr)39.11 ± 13.0339.61 ± 13.0340.11 ± 13.03NA
Duration (yr)12.78 ± 8.5313.28 ± 8.5313.78 ± 8.53NA
EDSS3.94 ± 2.253.94 ± 2.254.03 ± 2.18.633
  • Note:—NA indicates not applicable. The continuous measurements are presented as mean ± standard deviation. EDSS did not show significant changes during the follow-up period. Duration: the time since initial diagnosis of MS.